Trial · NCT05767515
The Effects of Acetyl-L-Carnitine and Myo/Chiro-Inositol in Patients With PCOS
NCT05767515, Not applicable, Completed, Khyber Medical University Peshawar
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Effects of Acetyl-L-Carnitine and Myo/Chiro-Inositol in Patients With PCOS. Trials, record NCT05767515. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05767515
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Effects of Acetyl-L-Carnitine and Myo/Chiro-Inositol in Patients With PCOS
- NCT number
- NCT05767515
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 120 participants, actual
- Lead sponsor
- Khyber Medical University Peshawar
- Conditions
- Infertility, Female, PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
- Interventions
- metformin
- First posted
- 2023-03-14
- Last updated
- 2026-02-09
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | CLINICAL PREGNANCY | 6 MONTHS | intrauterine pregnancy with positive fetal heart motion as determined on transvaginal ultrasound or HCG level is more than 1500IU/L |
| Secondary | OVULATION | 6 MONTHS | will be defined as serum Progesterone ( ≥3ng/ml or 9.54nmol/l) r on u/s examination |
| Secondary | Conception | 6 Months | positive serum level of HCG |
| Secondary | Biochemical Pregnancy | 6 months | Falling B-HCG concentration on serial determination |
| Secondary | tetosterone levels | 6 MONTHS | clinically on mFG , Biochemically on FAI |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers12
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05767515
GET https://conductscience.org/api/trials/v1/NCT05767515/registered